09-14-2018 03:31 PM CET - Health & Medicine

Global Fibromyalgia Treatment Market will multiply at an impressive CAGR by 2026 & Top Key Players Eli Lilly, Pfizer, Merck, Johnson & Johnson, GlaxoSmithKline, Novartis AG, Sanofi S.A., AstraZeneca, Allergan

Press release from: Coherent Market Insights
Fibromyalgia Treatment
Fibromyalgia Treatment

Coherent Market Insights has announced the addition of the “Fibromyalgia Treatment Market Size Status and Forecast 2026”, The report classifies the global Fibromyalgia Treatment Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth.

This report studies the global Fibromyalgia Treatment Speaker market, analyzes and researches the Fibromyalgia Treatment Speaker development status and forecast in North America, Europe, Asia Pacific, Latin America and Rest of the World. This report focuses on the top players in global market, like Eli Lilly, Pfizer, Merck, Johnson & Johnson, GlaxoSmithKline, Novartis AG, Sanofi S.A., AstraZeneca, Allergan

Request sample a copy: www.coherentmarketinsights.com/insight/request-sample/1691

Fibromyalgia is a common and complex chronic pain disorder that causes musculoskeletal pain, fatigue and localized tenderness affecting individuals mentally, physically and socially. Fibromyalgia is mainly caused due to genetic conditions, however actual cause is still unknown. The most common symptoms of fibromyalgia are fatigue, sleeping problems, chronic muscle pain and tender points. An individual with fibromyalgia can also have symptoms such as headaches, poor concentration and depression. Fibromyalgia symptoms can be gradually accumulated with the time or it can be done by some external factors. Fibromyalgia treatments include therapy, medications, regular aerobic exercise, stress reduction, and others. Furthermore, for treatment of Fibromyalgia antidepressants or pain medication are prescribed to treat depression, anxiety, pain, and fatigue.

Increasing prevalence of Fibromyalgia is expected to augment market growth. According to National Fibromyalgia and Chronic Pain Association, 2014, an estimated 210 million people in 2015, were affected with fibromyalgia syndrome, accounting for 2-4% of the total world population. Moreover, growth of the market is driven by increasing clinical trials by the manufacturers and research organizations and launch of novel diagnostics in order to reduce the burden of the disease with early and accurate disease diagnosis. For instance, in 2013, Innovative Med Concepts, LLC initiated the clinical trial for the drug candidate IMC-1, for the treatment of patients with fibromyalgia. Also, in March 2018, IQuity, a data science company launched a new blood test called Isolate Fibromyalgia, which uses RNA gene expression analysis to detect fibromyalgia, thus aiding in efficient diagnostics, which can provide early medical intervention.

On the basis of drug type, the global fibromyalgia treatment market is segmented into:

Savella (Milnacipran)
Cymbalta (Duloxetine)
Lyrica (Pregabalin)
Muscle Relaxants

On the basis of distribution channel, the global fibromyalgia treatment market is segmented into:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

The Fibromyalgia treatment market in Europe is expected to gain significant traction, owing to the presence of support groups providing online support combined with fund raising activities to make treatments available for the patients. For instance, the Fibromyalgia Action UK improves the lives of people with fibromyalgia by increasing awareness of the condition throughout the country, thereby improving awareness and access to treatments for fibromyalgia. Also, the UK Fibromyalgia, a member of Disability Rights UK, is focused on spreading awareness regarding Fibromyalgia condition through magazines and social media accounts, as well as encourages National Health Society (NHS) and private organizations to invest in new research projects.

Else place an Inquire before Purchase “Fibromyalgia Treatment Market Size, Status and Forecast 2026 : www.coherentmarketinsights.com/insight/talk-to-analyst/1691

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.
News-ID: 1240193 • Views: 451
More releases More releases

You can edit or delete your press release here: